Cerity Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Sell
19,959
-161,467
-89% -$7.66M ﹤0.01% 2070
2026
Q1
$9.36M Buy
+181,426
New +$12.7M 0.01% 723
2025
Q3
– Sell
-2,243
Closed -$291K – 2805
2025
Q2
$291K Sell
2,243
-4,116
-65% -$597K ﹤0.01% 2163
2025
Q1
$1.01M Sell
6,359
-5,403
-46% -$977K ﹤0.01% 1422
2024
Q4
$2.21M Sell
11,762
-1,814
-13% -$352K ﹤0.01% 1063
2024
Q3
$2.87M Buy
13,576
+10,910
+409% +$1.9M 0.01% 932
2024
Q2
$357K Buy
2,666
+1,596
+149% +$302K ﹤0.01% 1719
2024
Q1
$230K Buy
+1,070
New +$210K ﹤0.01% 2029

Other funds holding INSP

Cerity Partners's INSP Position: Q2 2026 in Review

Cerity Partners reduced its Inspire Medical Systems (INSP) stake by 89% in Q2 2026, selling an estimated $7.66M and leaving 19,959 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #2070.

Cerity Partners first reported a position in INSP in Q1 2024 and has held it in 8 quarters since. The position peaked at $9.36M in Q1 2026. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Cerity Partners held 19,959 shares of Inspire Medical Systems worth $890K as of Q2 2026.
  • Cerity Partners sold 161,467 Inspire Medical Systems shares in Q2 2026, an estimated $7.66M.
  • Inspire Medical Systems made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2070 holding.
  • Cerity Partners first reported a position in Inspire Medical Systems in Q1 2024 and has held it in 8 quarters since.
  • Cerity Partners's Inspire Medical Systems position peaked at $9.36M in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.